The frequency of genetic alterations in IKZF1 is approximately 15% in Philadelphia chromosome (Ph)-negative pediatric B-ALL and up to 30% in National Cancer Institute (NCI) high-risk, Ph-negative B-ALL [6,33]. The gene discussed is IKZF1; the disease is precursor B-cell acute lymphoblastic leukemia.